Article
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Breast cancer research and treatment - 1 Dec 2007
Macis Debora, Maisonneuve Patrick, Johansson Harriet, Bonanni Bernardo, Botteri Edoardo, Iodice Simona, Santillo Barbara, Penco Silvana, Gucciardo Giacomo, D'Aiuto Giuseppe, Rosselli Del Turco Marco, Amadori Marinella, Costa Alberto, Decensi Andrea
Abstract excerpt
BACKGROUND: A reduced activity of methylenetetrahydrofolate reductase (MTHFR) due to frequent C677T polymorphism affects DNA synthesis, repair and methylation and may be implicated in breast cancer risk. METHODS: We conducted a nested case-control study within a phase III prevention trial of tamo...
Topics
- Aged
- Aged, 80 and over
- Breast Neoplasms
- Case-Control Studies
- Clinical Trials, Phase III as Topic
- Female
- Genetic Predisposition to Disease
- Genotype
- Humans
- Methylenetetrahydrofolate Reductase (NADPH2)
- Middle Aged
- Multicenter Studies as Topic
